Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting
Conclusions
The analysis suggests that clopidogrel for secondary prevention is cost effective for patients with either PAD or recent IS in a Chinese setting in comparison with aspirin.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Clopidogrel | Drugs & Pharmacology | Ischemic Stroke | Peripheral Vascular Disease (PVD) | Plavix | Stroke | Study